BOSTON — In this Healio Video Perspective from the ASCRS meeting, Cody McKenzie of Glaukos discusses the anticipated impact of the iDose TR, which launched during the meeting.
He also announced that the travoprost intracameral implant, indicated for the reduction of IOP in open-angle glaucoma or ocular hypertension, received a permanent J-code, J7355, from CMS. The code will go into effect July 1.
“That will enable broader patient access as well as facilitate smooth claims processing,” McKenzie said.